IMMUNORESTORATIVE Trademark

Trademark Overview

On Wednesday, September 1, 2021, a trademark application was filed for IMMUNORESTORATIVE with the United States Patent and Trademark Office. The USPTO has given the IMMUNORESTORATIVE trademark a serial number of 97007251. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, June 17, 2022. This trademark is owned by Statera Biopharma, Inc.. The IMMUNORESTORATIVE trademark is filed in the Pharmaceutical Products, Education & Entertainment Services, and Computer & Software Services & Scientific Services categories with the following description:

Educational services, namely, conducting classes, seminars, conferences, and workshops and distributing printed course materials in conjunction therewith; providing on-line journals, namely, blogs in the medical, pharmaceutical and health fields

Pharmaceutical preparations and compounds for use in immune modulation, oncology, infectious diseases; pharmaceutical preparations for the treatment or prevention of immune-mediated diseases, Crohn's disease, multiple sclerosis, viral infections, HIV/AIDS, cancer, cell growth related disorders, cell proliferation related disorders, inflammatory diseases, ulcerative diseases, autoimmune diseases, autism, dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, stomach, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; anti-infectives; anti-inflammatories; vaccines; pharmaceutical preparations and compounds for reducing side effects in cancer treatment; pharmaceutical preparations and compounds for stimulating the immune system in an immuno-compromised patient; dietetic substances for medical purposes, namely, nutritional, vitamin and mineral ...

Pharmaceutical and therapeutics research and development services for systemically delivered, locally active immune restorative conjugates, small molecules and peptides; research and development of systemically delivered, locally active immune restorative conjugates, small molecules and peptides in the pharmaceutical, therapeutics and biotechnology fields; research and product development of systemically delivered, locally active immune restorative conjugates, small molecules and peptides in the field of human therapeutics; research services using a platform of biological research tools and techniques for use in the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases and fibrotic diseases with systemically delivered, locally active immune restorative conjugates, small molecules and peptides; pharmaceutical product development of systemically delivered, locally active immune restorative conjugates, small molecules and peptides
immunorestorative

General Information

Serial Number97007251
Word MarkIMMUNORESTORATIVE
Filing DateWednesday, September 1, 2021
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, June 17, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesEducational services, namely, conducting classes, seminars, conferences, and workshops and distributing printed course materials in conjunction therewith; providing on-line journals, namely, blogs in the medical, pharmaceutical and health fields
Goods and ServicesPharmaceutical preparations and compounds for use in immune modulation, oncology, infectious diseases; pharmaceutical preparations for the treatment or prevention of immune-mediated diseases, Crohn's disease, multiple sclerosis, viral infections, HIV/AIDS, cancer, cell growth related disorders, cell proliferation related disorders, inflammatory diseases, ulcerative diseases, autoimmune diseases, autism, dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, stomach, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; anti-infectives; anti-inflammatories; vaccines; pharmaceutical preparations and compounds for reducing side effects in cancer treatment; pharmaceutical preparations and compounds for stimulating the immune system in an immuno-compromised patient; dietetic substances for medical purposes, namely, nutritional, vitamin and mineral supplements
Goods and ServicesPharmaceutical and therapeutics research and development services for systemically delivered, locally active immune restorative conjugates, small molecules and peptides; research and development of systemically delivered, locally active immune restorative conjugates, small molecules and peptides in the pharmaceutical, therapeutics and biotechnology fields; research and product development of systemically delivered, locally active immune restorative conjugates, small molecules and peptides in the field of human therapeutics; research services using a platform of biological research tools and techniques for use in the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases and fibrotic diseases with systemically delivered, locally active immune restorative conjugates, small molecules and peptides; pharmaceutical product development of systemically delivered, locally active immune restorative conjugates, small molecules and peptides

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 14, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateThursday, October 14, 2021
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 14, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameStatera Biopharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFort Collins, CO 80526

Trademark Events

Event DateEvent Description
Friday, June 17, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 17, 2022NON-FINAL ACTION E-MAILED
Friday, June 17, 2022NON-FINAL ACTION WRITTEN
Monday, June 6, 2022ASSIGNED TO EXAMINER
Tuesday, January 18, 2022PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Saturday, January 15, 2022ASSIGNED TO LIE
Wednesday, January 12, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, October 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, September 4, 2021NEW APPLICATION ENTERED IN TRAM

Related Keywords

immunorestorative diseases immune pharmaceutical conjugates small molecules restorative active research delivered